Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatric Endocrinology

The Road Ahead: Monitoring Growth and Development

At a Glance

Most children with thyroid hypoplasia grow and develop well when they receive consistent levothyroxine and regular follow-up. Because the underdeveloped thyroid usually causes permanent hypothyroidism, medication should only be stopped for supervised blood testing led by a pediatric endocrinologist.

While the early days of a thyroid hypoplasia diagnosis are focused on urgent hormone replacement, the journey shifts over time to long-term monitoring and optimizing your child’s development. The good news is that for most children, early and consistent treatment with levothyroxine leads to healthy growth and normal brain development [1][2].

Reassessment: Permanent vs. Transient

Not every child diagnosed with congenital hypothyroidism will need medication for their entire life. In some cases, the condition is transient, meaning the thyroid eventually begins to produce enough hormone on its own [3].

However, children with thyroid hypoplasia (a structurally underdeveloped gland), agenesis, or ectopia have structural dysgenesis and usually have permanent hypothyroidism requiring lifelong treatment [4]. A trial off medication to reassess the condition is generally reserved for cases in which permanence is uncertain, such as a normal gland on imaging or a mild/uncertain initial diagnosis.

Because the thyroid is so critical for brain development during the first few years, doctors typically wait until a child is 2 to 3 years old to perform a formal reassessment if one is indicated [3][5].

  • The Trial Off Medication: Under strict medical supervision, the levothyroxine is paused. The exact withdrawal protocol and duration are laboratory- and clinician-specific [6].
  • The Testing: Blood tests are then performed to see if the body can maintain normal TSH and free T4 levels without help.
  • The Result: If the levels remain normal, the condition is reclassified as transient. If the TSH rises above specific thresholds determined by the lab, the condition is confirmed as permanent, and medication is restarted [7][8].

Safety Note: Only the endocrinologist should decide whether and how to trial withdrawal. Never stop or adjust levothyroxine on your own.

Long-Term Monitoring Priorities

As your child grows, their care team will monitor more than just their blood levels. These check-ups are designed to ensure every part of their development is on track:

  • Growth and Bone Age: Your doctor will track height, weight, and head circumference at every visit. Occasionally, they may order a bone age X-ray (usually of the hand and wrist). Bone-age radiographs are not routine in every well-treated child and are generally reserved for a specific growth or treatment concern [9][10].
  • Neurodevelopment: This includes monitoring milestones like crawling, walking, and speaking. For school-aged children, monitoring focus, memory, and academic performance is important, as subtle learning challenges can sometimes occur even with treatment [2][11].
  • Syndromic Monitoring: In rare cases where hypoplasia is linked to specific genes, additional screenings may be indicated. For instance, FOXE1-related disease is more relevant to cleft palate or choanal abnormalities, while NKX2-1-related disease has neurologic and respiratory manifestations. Additional testing should be gene- and clinically directed [12][13].

Signs That Need Urgent Attention

While your scheduled blood tests are the best way to monitor treatment, you cannot reliably tell if the dose is too low or too high based on symptoms alone. Do not adjust levothyroxine based on symptoms; use laboratory results and clinician guidance.

However, if you notice the following severe signs, seek explicit emergency escalation or immediate urgent evaluation (do not simply leave a message for the clinic):

  • Severe lethargy, extreme difficulty waking, or unresponsiveness.
  • Severe feeding refusal or signs of dehydration (e.g., no wet diapers).
  • Persistent rapid heartbeat (racing heart even while resting).
  • Breathing difficulty.

Looking Ahead

The diagnosis of thyroid hypoplasia does not define your child’s potential. By maintaining a close partnership with your pediatric endocrinologist and ensuring your child never misses a dose, you are providing the “fuel” they need to thrive. Most children treated adequately grow, learn, and develop well, navigating a standard school and social life alongside their peers [1][14].

Common questions in this guide

Is thyroid hypoplasia usually permanent in children?
Yes. A thyroid gland that is structurally underdeveloped usually cannot make enough hormone, so hypothyroidism is generally permanent and requires ongoing levothyroxine. An endocrinologist may consider a supervised trial off medicine only when imaging or the initial diagnosis leaves the long-term outlook uncertain.
How is it determined whether my child still needs thyroid medicine?
If permanence is uncertain, an endocrinologist may wait until the child is about 2 to 3 years old, pause levothyroxine under supervision, and check TSH and free T4 in blood. Normal results may support transient hypothyroidism, while a rise in TSH supports permanent disease and restarting treatment. Do not stop or change levothyroxine without medical instructions.
What will doctors check during long-term follow-up?
They usually track height, weight, and head circumference, and ask about developmental milestones such as walking and speech. As children get older, the team may also discuss focus, memory, and school performance. A bone-age X-ray is used only when a specific growth or treatment concern makes it appropriate.
Can children with thyroid hypoplasia grow and learn normally?
Most children do well when levothyroxine is started early, taken consistently, and adjusted using blood-test results. Regular follow-up helps the care team identify growth, developmental, or learning concerns early. Many children attend regular schools and participate in typical social activities.
What symptoms mean my child needs urgent medical attention?
Seek immediate urgent evaluation for severe lethargy, extreme difficulty waking, unresponsiveness, severe feeding refusal, signs of dehydration such as no wet diapers, a persistent racing heartbeat at rest, or breathing difficulty. These signs should not be managed by simply leaving a message for the clinic. Do not change the levothyroxine dose based on symptoms alone.
Could my child need screening for other conditions?
Some children with gene-related thyroid hypoplasia may need additional, gene-specific evaluation. FOXE1-related disease can be associated with cleft palate or blocked nasal passages, while NKX2-1-related disease can involve neurologic or breathing problems. The child’s clinician should decide which screening is appropriate based on the child’s findings and genetic results.

Get notified when new evidence is published on Thyroid hypoplasia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Improvements in screening test, diagnosis, and outcomes of children with congenital hypothyroidism: lessons learned from 50 years of newborn screening.

    Salerno M, Vigone MC, Cassio A, et al.

    Endocrine 2026; (91(1)).

    PMID: 42257811
  2. 2

    Evaluation and management of the child with hypothyroidism.

    Leung AKC, Leung AAC

    World journal of pediatrics : WJP 2019; (15(2)):124-134 doi:10.1007/s12519-019-00230-w.

    PMID: 30734891
  3. 3

    Predicting variables associated with diagnostic reevaluation of transient congenital hypothyroidism.

    Gwag SH, Park KH, Kang E, et al.

    Annals of pediatric endocrinology & metabolism 2025; (30(3)):127-134 doi:10.6065/apem.2448164.082.

    PMID: 40624913
  4. 4

    Permanent vs Transient Congenital Hypothyroidism: Assessment of Predictive Variables.

    Oron T, Lazar L, Ben-Yishai S, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(12)):4428-4436 doi:10.1210/jc.2018-00362.

    PMID: 30272179
  5. 5

    Congenital Hypothyroidism: Screening and Management.

    Rose SR, Wassner AJ, Wintergerst KA, et al.

    Pediatrics 2023; (151(1)) doi:10.1542/peds.2022-060419.

    PMID: 36827523
  6. 6

    Diagnostic re-evaluation of congenital hypothyroidism in Macedonia: predictors for transient or permanent hypothyroidism.

    Zdraveska N, Zdravkovska M, Anastasovska V, et al.

    Endocrine connections 2018; (7(2)):278-285 doi:10.1530/EC-17-0332.

    PMID: 29335252
  7. 7

    Permanent and Transient Congenital Hypothyroidism in Hamadan West Province of Iran.

    Razavi Z, Mohammadi L

    International journal of endocrinology and metabolism 2016; (14(4)):e38256 doi:10.5812/ijem.38256.

    PMID: 28144251
  8. 8

    Comparison between transient and permanent congenital hypothyroidism on a thyroid function test after re-evaluation.

    Lee SH, Lee HG, Yang EM, Kim CJ

    Annals of pediatric endocrinology & metabolism 2023; (28(4)):245-250 doi:10.6065/apem.2244260.130.

    PMID: 38173380
  9. 9

    Congenital hypothyroidism in children with eutopic gland or thyroid hemiagenesis: prognostic factors for transient vs. permanent hypothyroidism.

    Bontemps SH, Legagneur C, Guéant-Rodriguez RM, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(4)):353-363 doi:10.1515/jpem-2022-0101.

    PMID: 36798001
  10. 10

    Transient hypothyroidism in a neonate following maternal exposure to vinblastine during pregnancy: a case report and review.

    Amin Z, Aung WT, Ng YPM

    Frontiers in pediatrics 2024; (12()):1464520 doi:10.3389/fped.2024.1464520.

    PMID: 39764160
  11. 11

    An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

    Stagi S, Municchi G, Ferrari M, Wasniewska MG

    Frontiers in endocrinology 2022; (13()):859487 doi:10.3389/fendo.2022.859487.

    PMID: 35757415
  12. 12

    A new FOXE1 homozygous frameshift variant expands the genotypic and phenotypic spectrum of Bamforth-Lazarus syndrome.

    Sarma AS, Banda L, Rao Vupputuri M, et al.

    European journal of medical genetics 2022; (65(10)):104591 doi:10.1016/j.ejmg.2022.104591.

    PMID: 35963604
  13. 13

    Hearing thresholds and ventilation tube treatment in children with unilateral cleft lip and palate.

    Tengroth B, Hederstierna C, Neovius E, Flynn T

    International journal of pediatric otorhinolaryngology 2017; (97()):102-108 doi:10.1016/j.ijporl.2017.03.031.

    PMID: 28483218
  14. 14

    Normal intellectual ability and hyperprolactinemia as unique clinical manifestations of congenital hypothyroidism: A case report and review of hypotheses.

    Zulfa PO, Debbyousha M, Sucipto KW, et al.

    Narra J 2023; (3(3)):e205 doi:10.52225/narra.v3i3.205.

    PMID: 38455622

This page is for informational purposes only and does not constitute medical advice. Your child’s pediatric endocrinologist should guide levothyroxine changes, reassessment, and urgent care.